Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoglobin-based oxygen carriers.

A Gerson Greenburg1, Hae Won Kim

  • 1Brown University School of Medicine, Providence, Rhode Island, USA. aggreenb@lifespan.org

Critical Care (London, England)
|June 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Pathological Features and Molecular Markers in Alzheimer's Disease.

International journal of molecular sciences·2026
Same author

The Central Role of Neuronal Cell Death in Alzheimer's Disease Pathobiology.

Biomedicines·2026
Same author

The impact of a brief web-based intervention on improving intention and awareness related to reducing alcohol consumption during pregnancy among high-risk female college student drinkers: a quasi-experimental study.

Women's health nursing (Seoul, Korea)·2026
Same author

Neuroprotective effects of α-lipoic acid on ischemia/reperfusion injury in global cerebral ischemia mouse model.

Scientific reports·2025
Same author

Western diet-induced visceral adipose tissue inflammation promotes Alzheimer's disease pathology via microglial activation in a mouse model.

Frontiers in aging neuroscience·2025
Same author

Impact of Enhanced Dietary Education Program on Gastrointestinal Symptoms in Patients With Functional Gastrointestinal Disorders: A Multicenter Prospective Pilot Study.

Journal of neurogastroenterology and motility·2025
Same journal

Obesity: biomechanical implications for mechanical ventilation.

Critical care (London, England)·2026
Same journal

Combined trauma and toxic inhalation in war and disaster medicine: alveolar-capillary barrier failure and respiratory countermeasures.

Critical care (London, England)·2026
Same journal

The molecular ICU: a primer on omics, informatics and the future of precision critical care.

Critical care (London, England)·2026
Same journal

Bilateral radial arterial pressure concordance as a real-time bedside marker of native cardiac recovery during peripheral VA-ECMO weaning.

Critical care (London, England)·2026
Same journal

Beyond shear stress: septic microvascular failure remains a multifactorial phenomenon.

Critical care (London, England)·2026
Same journal

Anticoagulation-free VV-ECMO: expanding the evidence beyond trauma.

Critical care (London, England)·2026
See all related articles

Hemoglobin-based oxygen carriers offer alternatives to red blood cell transfusion, aiming to preserve tissue perfusion. Clinical trials are ongoing for human and bovine solutions, with avoidance of allogeneic transfusion as a key efficacy endpoint.

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Surgical Innovation

Background:

  • Red blood cell transfusions are critical but carry risks.
  • Hemoglobin-based oxygen carriers (HBOCs) are being developed as transfusion alternatives.
  • Challenges in HBOC development include molecular design, safety, and efficacy.

Purpose of the Study:

  • To provide an update on the clinical trial status of leading HBOC candidates.
  • To discuss the potential utility of HBOCs in surgical settings.
  • To explore the combination of HBOCs with intraoperative autologous donation.

Main Methods:

  • Review of clinical trial data for HBOCs.
  • Analysis of efficacy endpoints, focusing on avoidance of allogeneic transfusion.

Related Experiment Videos

  • Discussion of HBOC applications in surgical procedures.

    • Main Results:

    • Three leading HBOC candidates have emerged: PolyHeme, HemoLink (human-based), and Hemopure (bovine-based).
    • Demonstrating a survival benefit has been challenging, leading to the adoption of transfusion avoidance as an efficacy endpoint.
    • Clinical testing has addressed molecular design, safety, and regulatory hurdles.

    Conclusions:

    • HBOCs show promise in preserving tissue perfusion and minimizing hypoxic damage.
    • Avoidance of allogeneic transfusion is the current standard for demonstrating HBOC efficacy.
    • HBOCs may offer significant benefits in surgical patients, potentially combined with autologous donation.